C07K 16/1203
Gram-negative bacteria
C07K16/1203 (Gram-negative bacteria) appears on 1,156 US grants and 1,365 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,156
- Published applications
- 1,365
- Assignees
- 719
- Inventors
- 2,376
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 7 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 7 | 0 |
| 1988 | 10 | 0 |
| 1989 | 8 | 0 |
| 1990 | 7 | 0 |
| 1991 | 10 | 0 |
| 1992 | 13 | 0 |
| 1993 | 19 | 0 |
| 1994 | 9 | 0 |
| 1995 | 9 | 0 |
| 1996 | 17 | 0 |
| 1997 | 25 | 0 |
| 1998 | 37 | 0 |
| 1999 | 30 | 0 |
| 2000 | 29 | 0 |
| 2001 | 26 | 6 |
| 2002 | 18 | 27 |
| 2003 | 26 | 48 |
| 2004 | 24 | 50 |
| 2005 | 17 | 45 |
| 2006 | 19 | 31 |
| 2007 | 33 | 47 |
| 2008 | 28 | 32 |
| 2009 | 27 | 55 |
| 2010 | 34 | 48 |
| 2011 | 35 | 67 |
| 2012 | 35 | 64 |
| 2013 | 31 | 60 |
| 2014 | 47 | 77 |
| 2015 | 52 | 70 |
| 2016 | 59 | 93 |
| 2017 | 46 | 72 |
| 2018 | 58 | 66 |
| 2019 | 50 | 58 |
| 2020 | 50 | 59 |
| 2021 | 43 | 61 |
| 2022 | 29 | 52 |
| 2023 | 28 | 53 |
| 2024 | 32 | 56 |
| 2025 | 42 | 41 |
| 2026 | 16 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Engineered binding proteins for recognition of bacteria11 Aug 2026US 12,704,514 B2Massachusetts Institute of Technology
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof30 Jun 2026US 12,668,645 B2ModeX Therapeutics, Inc.
- Monoclonal antibody and vaccine targeting filamentous bacteriophage23 Jun 2026US 12,661,411 B2Inimmune Corporation
- Antigen-binding molecules that bind to Porphyromonas gingivalis26 May 2026US 12,637,503 B2K-Bio Investment, LLC
- Ehrlichia vaccines and immunogenic compositions12 May 2026US 12,624,093 B2Research Development Foundation
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
- Antibodies17 Sep 2026US 2026/0273037 A1Hydrosense Ltd
- Anti-etec adhesin protein antibodies and methods of use17 Sep 2026US 2026/0274929 A1University of Massachusetts
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof17 Sep 2026US 2026/0274995 A1ModeX Therapeutics, Inc.
- Vaccines targeting pseudomonas aeruginosa10 Sep 2026US 2026/0265312 A1Evaxion Biotech A/S
Most cited
By later US patents
- Transgenic plants expressing assembled secretory antibodies319US 5,959,177 AThe Scripps Research Institute · 1999
- Transgenic plants expressing assembled secretory antibodies273US 6,417,429 B1The Scripps Research Institute · 2002
- High affinity human antibodies and human antibodies against digoxin211US 6,255,458 B1GenPharm International, Inc. · 2001
- Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria112US 4,918,163 APfizer Inc. · 1990
- Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli104US 8,758,764 B2J. Craig Venter Institute, Inc. · 2014